Based on these results, HDAC7 is involved in WNT5A-mediated ESCC progression, and approaches targeting WNT5A and HDAC7 might be potential therapeutic strategies for ESCC. This evidence concerns the gene HDAC7 and esophageal squamous cell carcinoma.